Krieg, S. M., Schnurbus, L., Shiban, E., Droese, D., Obermueller, T., Buchmann, N., . . . Ringel, F. (2013). Surgery of highly eloquent gliomas primarily assessed as non-resectable: Risks and benefits in a cohort study. BioMed Central.
Dyfyniad Arddull ChicagoKrieg, Sandro M., Lea Schnurbus, Ehab Shiban, Doris Droese, Thomas Obermueller, Niels Buchmann, Jens Gempt, Bernhard Meyer, and Florian Ringel. Surgery of Highly Eloquent Gliomas Primarily Assessed As Non-resectable: Risks and Benefits in a Cohort Study. BioMed Central, 2013.
Dyfyniad MLAKrieg, Sandro M., et al. Surgery of Highly Eloquent Gliomas Primarily Assessed As Non-resectable: Risks and Benefits in a Cohort Study. BioMed Central, 2013.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.